6A. E. Civitarese,C. P. Jenkinson,D. Richardson,M. Bajaj,K. Cusi,S. Kashyap,R. Berria,R. Belfort,R. A. DeFronzo,L. J. Mandarino,E. Ravussin.Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes[J].Diabetologia.2004(5)
7Francine Ratner Kaufman.Type 2 Diabetes in Children and Youth[J].Reviews in Endocrine and Metabolic Disorders.2003(1)
8Veening MA,Van Weissenbruch MM,Delemarre-Van De Waal HA.Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age[].Journal of Clinical Endocrinology and Metabolism.2002
9Yajnik,CS,Lubree,HG,Rege,SS.Adiposity and hyperinsulinemia in Indians are present at birth[].The Journal of Clinical Endocrinology.2002
10Freemark M,Bursey D.The effect of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes[].Pediatrics.2001
2Yanagisa wa M,et al.A novel potent vasoconstrictor peptide produced by endothelial cells.Nature,1988,332:411.
3Verdccchia P,et al.Blood pressure monitoring.Task force Ⅲ:Target-organdamage,morbidity and mrotality.Blood press monit,1999,4167:30.
4Pasquali R , Gambineri A , Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary sy
5Homburg R, Orvieto R, Bar-Hava I, et al. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome[J]. Hum Reprod, 1996,11(4): 716-719.
6Vermeulen A, Verclonck L, Kautman JM,et al. A critical evaluation of simple methods for the estimation of free testerone in serum[J]. J Clin Endocrinol Metab ,1999, 84(10):3666-3672.
7De Leo V, La Marca A, Orvieto R, et al. Effect of metformin on insulin-like growth factor-1 and IGF binding protein-1 in polycystic ovary syndrome[J]. J Clin Endocrinol Metab,2000,85(4):1598-1600.
8Verma S, Mather K, Dumont AS, et al. Pharmacological modulation of insulin resistance and hyperinsulinemia in polycystic ovary syndrome[J]. The Endocrinologist , 1998,8(6): 418-424.
9El Orabi H, Ghalia AA, Khalifa A, et al. Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome[J]. Clin Biochem ,1999, 32(1) : 71-75.
